MMC International

Home

MMC Service Offerings

About MMC International

Background

History

Tradition

Client Service

Strategy

General Management

Business Development

Marketing And Sales

Issues Discussions

Strategic Consulting

Personalized Medicine

Disease Area Roadmap

Target Product Profile

Life Cycle Management

MMC Insights

Rx Ind. Strategic Reports

U.S. Rx Trends Report

Licensing and M&A Reports

Global Oncology Review

MMC Message Board

Add/Update Contact Info

Comments

Contact Us

Driving Directions

Employment

For MMC Consultants

Loading
Trends Shaping U.S. Pharmaceutical Industry Strategies Report, Tenth Edition

The Patient Protection and Affordable Care Act, signed into law on March 23, 2010, and related legislation and regulations, will result in the total transformation of U.S. healthcare industry norms over the next ten years - far exceeding the transformational impact of the HMO Act of 1973 and implementation of DRGs in 1983 combined. 

The next ten years will be an unprecedented period of: 1) innovation and 2) implementation of technologies that have been in development over the previous 20 to 30 years that will fundamentally affect pharmaceutical industry strategy, product portfolios, clinical trials, regulatory submissions, business development, manufacturing, marketing, sales, resource allocations and organizational structures.  Periods of instability are fraught with risk and significant opportunity.  For pharmaceuticals, unearthing opportunities requires an understanding of changing healthcare industry legislation and regulation, industry roles, where different technologies are in their implementation cycles (e.g., electronic health records, telemedicine, etc.), changing customer needs, new customers and new influencers, the proper application of strategic concepts, and redefined value propositions.  The "ALL NEW" Tenth Edition presents analysis designed to unearth the most eye-opening pharmaceutical company implications which typically lurk at the intersections where multiple trends (and dozens or more sub-trends) interact with one another, often in complex and not so obvious ways.  These insights identify value creating opportunities as well as potential threats.  These are the trends and issues addressed in the totally new 10th Edition of the Trends Shaping U.S. Pharmaceutical Industry Strategies report. 

The analyses show that strategy and execution will increasingly be what separates the successful companies from those that will be merged, acquired, or driven out of business. 

Please go to the respective section below to:

1. view a pdf copy of the report brochure (a copy of the order form is on the back page), or
2. download a pdf copy of the order form. 


Report Brochure

Please be patient as this is a large file (6 MB) that may take a few minutes to download.
Brochure - Trends Shaping U.S. Pharmaceutical Industry Strategies, 10th Edition
Order Form

To order the Trends Shaping U.S. Pharmaceutical Industry Strategies report, Tenth Edition, please click on the link below, fill out and sign the Order Form, and fax a copy to 203-547-6307.
Order Form - Trends Shaping U.S. Pharmaceutical Industry Strategies, 10th Edition
 
 
 
For more information, please contact your MMC representative, call Ed Valentine at 203-961-9352 or e-mail hime at: e.valentine@mmcint.com, or fill out the Contact Us request on the website.
 
© By MMC International, 1985 - 2010.  All rights reserved.

From Strategy To Implementation